Strides Pharma Testosterone Gel Benzene Contamination Class Action Settlement
Strides Pharma has agreed to settle a class action over benzene contamination found in certain testosterone gel products. If you used or purchased affected Strides Pharma testosterone gel, you may be entitled to cash compensation — but proof of purchase or use is required.
Do I Qualify?
You may be eligible if:
- Individuals who purchased or used Strides Pharma testosterone gel products identified in the settlement notice
- Products were found to contain benzene, a known carcinogen, above acceptable levels
- Proof of purchase, prescription records, or pharmacy records are required
- You submit a valid claim with documentation by September 16, 2026
Proof is required. You must submit purchase records, prescription records, pharmacy records, or other documentation showing you purchased or used the affected testosterone gel products.
File your claim through the official settlement website.
File Your Claim →What Happened?
Strides Pharma, a pharmaceutical manufacturer, faced class action lawsuits after benzene — a known human carcinogen linked to leukemia and other cancers — was detected in certain testosterone gel products. Benzene contamination in pharmaceutical products can occur during manufacturing and poses serious health risks to patients who use the products regularly.
The FDA and independent testing identified elevated benzene levels in affected batches. Strides Pharma agreed to settle the nationwide class action while denying liability. The claim deadline is September 16, 2026 — not July 30 as incorrectly reported on some aggregator sites.
How Much Will I Actually Get?
Payment amounts depend on the number of valid claims filed and the tier of compensation you qualify for under the settlement plan. Proof of purchase or use is required. File at StridesGelSettlement.com by September 16, 2026.
Last reviewed: June 22, 2026 | Information verified from court records and official settlement documents.